4th Quarter - Report

COVINGTON & BURLING LLP for CELGENE CORPORATION

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Expressing support for changes to the CREATES Act (H.R. 2212, S. 974) and Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051).

LobbyistCovered position, as disclosed
GARY HEIMBERG New —
GABRIEL NEVILLE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 974 (115th), H.R. 2212 (115th), H.R. 2051 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.